CLINICAL_TRIALS
trial_result
· 2019-10-10
Clinical Trial Update: Melatonin for Prevention of Post Stroke Delirium [Phase 2, Phase 3]
Summary
A clinical trial update on using melatonin to prevent post-stroke delirium across Phase 2 and Phase 3 stages.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospital Tuebingen | Conditions: Post Stroke Delirium | Phase 2, Phase 3 | Status: UNKNOWN